What was the overall market valuation of the custom antibody market in 2024?

The overall market valuation was $6.0 Million in 2024. Read More

What is the projected market valuation for the custom antibody market in 2035?

The projected valuation for 2035 is $15.07 Million. Read More

What is the expected CAGR for the custom antibody market during the forecast period 2025 - 2035?

The expected CAGR for the market during the forecast period 2025 - 2035 is 8.73%. Read More

Which companies are considered key players in the custom antibody market?

Key players include Thermo Fisher Scientific, Abcam, GenScript, Merck KGaA, R&D Systems, Bio-Rad Laboratories, Cell Signaling Technology, Santa Cruz Biotechnology, and Sigma-Aldrich. Read More

What were the revenue figures for antibody development services in 2024?

Antibody development services generated $2.4 Million in 2024 and are projected to reach $5.0 Million. Read More

How did the antibody production and purification segment perform in 2024?

The antibody production and purification segment recorded $2.0 Million in 2024, with projections of $4.5 Million. Read More

What is the revenue forecast for monoclonal antibodies by 2035?

Monoclonal antibodies are expected to generate $5.0 Million by 2035. Read More

What was the market size for the neurobiology research area in 2024?

The neurobiology research area had a market size of $1.2 Million in 2024, with a forecast of $2.5 Million. Read More

Which end-user segment is projected to grow the most by 2035?

Biotechnology companies are projected to grow from $1.8 Million in 2024 to $4.0 Million by 2035. Read More

What were the revenue figures for polyclonal antibodies in 2024?

Polyclonal antibodies generated $1.8 Million in 2024, with projections of $3.5 Million. Read More

GCC Custom Antibody Market

ID: MRFR/HC/51851-HCR

200 Pages

Rahul Gotadki

Last Updated: April 06, 2026

GCC Custom Antibody Market Research Report By Service (Antibody Development, Antibody Production & Purification, Antibody Fragmentation & Labelling), By Source (Mice, Others), By Research Area (Oncology, Neurobiology, Infectious Diseases, Immunology, Others), By Type (Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibody, Other Custom Antibodies) and By End Users (Hospitals & Clinics, Academic & Research Institute, Contact Research Organization, Biotechnology Companies, Others) - Growth & Industry Forecast 2025 To 2035

Summary Table of Contents Segmentation Download PDF

Certified Researchers

Customize Report

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Chemicals and Materials, BY Service (USD Million)
  1. 4.1.1 Antibody Development
  2. 4.1.2 Antibody Production & Purification
  3. 4.1.3 Antibody Fragmentation & Labelling
2. 4.2 Chemicals and Materials, BY Source (USD Million)
  1. 4.2.1 Mice
  2. 4.2.2 Others
3. 4.3 Chemicals and Materials, BY Research Area (USD Million)
  1. 4.3.1 Oncology
  2. 4.3.2 Neurobiology
  3. 4.3.3 Infectious Diseases
  4. 4.3.4 Immunology
  5. 4.3.5 Others
4. 4.4 Chemicals and Materials, BY Type (USD Million)
  1. 4.4.1 Monoclonal Antibodies
  2. 4.4.2 Polyclonal Antibodies
  3. 4.4.3 Recombinant Antibody
  4. 4.4.4 Other Custom Antibodies
5. 4.5 Chemicals and Materials, BY End Users (USD Million)
  1. 4.5.1 Biotechnology Companies
  2. 4.5.2 Hospital & Clinics
  3. 4.5.3 Academic & Research Institutes
  4. 4.5.4 Contract Research Organizations
  5. 4.5.5 Others
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Chemicals and Materials
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Chemicals and Materials
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Thermo Fisher Scientific (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Abcam (GB)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 GenScript (CN)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Merck KGaA (DE)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 R&D Systems (US)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Bio-Rad Laboratories (US)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Cell Signaling Technology (US)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Santa Cruz Biotechnology (US)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
  9. 5.2.9 Sigma-Aldrich (US)
    1. 5.2.9.1 Financial Overview
    2. 5.2.9.2 Products Offered
    3. 5.2.9.3 Key Developments
    4. 5.2.9.4 SWOT Analysis
    5. 5.2.9.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 GCC MARKET ANALYSIS BY SERVICE
3. 6.3 GCC MARKET ANALYSIS BY SOURCE
4. 6.4 GCC MARKET ANALYSIS BY RESEARCH AREA
5. 6.5 GCC MARKET ANALYSIS BY TYPE
6. 6.6 GCC MARKET ANALYSIS BY END USERS
7. 6.7 KEY BUYING CRITERIA OF CHEMICALS AND MATERIALS
8. 6.8 RESEARCH PROCESS OF MRFR
9. 6.9 DRO ANALYSIS OF CHEMICALS AND MATERIALS
10. 6.10 DRIVERS IMPACT ANALYSIS: CHEMICALS AND MATERIALS
11. 6.11 RESTRAINTS IMPACT ANALYSIS: CHEMICALS AND MATERIALS
12. 6.12 SUPPLY / VALUE CHAIN: CHEMICALS AND MATERIALS
13. 6.13 CHEMICALS AND MATERIALS, BY SERVICE, 2024 (% SHARE)
14. 6.14 CHEMICALS AND MATERIALS, BY SERVICE, 2024 TO 2035 (USD Million)
15. 6.15 CHEMICALS AND MATERIALS, BY SOURCE, 2024 (% SHARE)
16. 6.16 CHEMICALS AND MATERIALS, BY SOURCE, 2024 TO 2035 (USD Million)
17. 6.17 CHEMICALS AND MATERIALS, BY RESEARCH AREA, 2024 (% SHARE)
18. 6.18 CHEMICALS AND MATERIALS, BY RESEARCH AREA, 2024 TO 2035 (USD Million)
19. 6.19 CHEMICALS AND MATERIALS, BY TYPE, 2024 (% SHARE)
20. 6.20 CHEMICALS AND MATERIALS, BY TYPE, 2024 TO 2035 (USD Million)
21. 6.21 CHEMICALS AND MATERIALS, BY END USERS, 2024 (% SHARE)
22. 6.22 CHEMICALS AND MATERIALS, BY END USERS, 2024 TO 2035 (USD Million)
23. 6.23 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 GCC MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY SERVICE, 2025-2035 (USD Million)
  2. 7.2.2 BY SOURCE, 2025-2035 (USD Million)
  3. 7.2.3 BY RESEARCH AREA, 2025-2035 (USD Million)
  4. 7.2.4 BY TYPE, 2025-2035 (USD Million)
  5. 7.2.5 BY END USERS, 2025-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

GCC Chemicals and Materials Market Segmentation

Chemicals and Materials By Service (USD Million, 2025-2035)

Antibody Development
Antibody Production & Purification
Antibody Fragmentation & Labelling

Chemicals and Materials By Source (USD Million, 2025-2035)

Mice
Others

Chemicals and Materials By Research Area (USD Million, 2025-2035)

Oncology
Neurobiology
Infectious Diseases
Immunology
Others

Chemicals and Materials By Type (USD Million, 2025-2035)

Monoclonal Antibodies
Polyclonal Antibodies
Recombinant Antibody
Other Custom Antibodies

Chemicals and Materials By End Users (USD Million, 2025-2035)

Biotechnology Companies
Hospital & Clinics
Academic & Research Institutes
Contract Research Organizations
Others

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”